Stock Events

Stock Events

Mydecine Innovations Group 

$1.1615
50
-$0.34-22.57% Wednesday 19:11

Statistics

Day High
2
Day Low
2
52W High
2.04
52W Low
0.029
Volume
200
Avg. Volume
509
Mkt Cap
68M
P/E Ratio
1.13
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17AugExpected
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q1 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
0Revenue
2.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MYCOF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.84B
Compass Pathways focuses on psilocybin therapy for mental health disorders, directly competing in the psychedelic medicine space with Mydecine Innovations.
ATAI Life Sciences N.V.
ATAI
Mkt Cap1.91B
ATAI Life Sciences is a biotech company working on mental health treatments using psychedelics, overlapping with Mydecine's focus areas.
GH Research
GHRS
Mkt Cap1.85B
GH Research focuses on developing 5-MeO-DMT therapies for depression, competing in the psychedelic treatment market.
Revive Therapeutics
RVVTF
Mkt Cap8.71M
Revive Therapeutics is exploring the use of psychedelics for medical treatments, including areas Mydecine Innovations is involved in.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is engaged in psychedelic production and therapy, directly competing with Mydecine's business model.
TripAdvisor
TRIP
Mkt Cap1.66B
Red Light Holland is involved in the production and sale of recreational truffles, indirectly competing by promoting psychedelic acceptance.

About

Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Robert Roscow M.A.
Employees
3
Country
Canada
ISIN
CA62849F1018

Listings

STU
DE
0NF1.STU
CN
CA
NVRS.CN
MU
DE
0NFA.MU
STU
DE
0NFA.STU

0 Comments

Share your thoughts

FAQ

What is Mydecine Innovations Group stock price today?▼
The current price of MYCOF is $1.16 USD — it has decreased by -22.57% in the past 24 hours. Watch Mydecine Innovations Group stock price performance more closely on the chart.
What is Mydecine Innovations Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Mydecine Innovations Group stocks are traded under the ticker MYCOF.
Is Mydecine Innovations Group stock price growing?▼
MYCOF stock has fallen by -41.93% compared to the previous week, the month change is a -41.93% fall, over the last year Mydecine Innovations Group has showed a +674.33% increase.
What is Mydecine Innovations Group market cap?▼
Today Mydecine Innovations Group has the market capitalization of 68M
When is the next Mydecine Innovations Group earnings date?▼
Mydecine Innovations Group is going to release the next earnings report on August 17, 2026.
What is Mydecine Innovations Group revenue for the last year?▼
Mydecine Innovations Group revenue for the last year amounts to 0 USD.
What is Mydecine Innovations Group net income for the last year?▼
MYCOF net income for the last year is 2.14M USD.
How many employees does Mydecine Innovations Group have?▼
As of July 09, 2026, the company has 3 employees.
In which sector is Mydecine Innovations Group located?▼
Mydecine Innovations Group operates in the Health & Wellness sector.
When did Mydecine Innovations Group complete a stock split?▼
The last stock split for Mydecine Innovations Group was on October 21, 2025 with a ratio of 1:50.
Where is Mydecine Innovations Group headquartered?▼
Mydecine Innovations Group is headquartered in Vancouver, Canada.